Biomedical Systems' newest office resides in the city of Pondicherry, located 300 kilometers from Bangalore on the southeast coast of India. This is Biomedical Systems’ fourth business center, joining St. Louis, Missouri; Brussels, Belgium and Tsukuba, Japan. The facility will provide pharmaceutical sponsors with an in-country resource for site training, query resolution, 24/7 technical support and logistics for clinical trial equipment and supplies. The Pondicherry office will provide a local presence to assist our sponsors to obtain quality clinical trial data in India for cardiac safety and efficacy, respiratory and imaging studies. A recent Ernst and Young report shows that India’s outsourcing sector is growing at 43%. Its growth and importance in the area of drug development cannot be overlooked. Opening this office reaffirms Biomedical Systems’ continued commitment to providing industry leading customer service to our clients. 

Growth in India's Biotech Market

India's biotech industry reports revenue increasing by more than half over the past year. FierceBiotech, an industry leading newsletter for the biotech/biopharma industry reports that a leading biotech executive in the subcontinent, Kiran Mazumdar-Shaw, says that the industry is poised for another big year ahead as international developers look to India for low-cost drug discovery and manufacturing work.

"India has emerged as an attractive market for the global pharma sector, as evident from increasing investment flows into the country. We offer huge cost advantages with high value of services," says Shaw, the chairperson of Biocon. Shaw cited clinical data management and discovery work as two key areas that India has developed key expertise on. And with developers the world over looking for more efficient ways to develop new therapies, Shaw estimates that the overall revenue for the industry will soon break the $5 billion mark.

Speaking to a biotech summit held in Bangalore, the industry outlined plans for a new venture fund to back start-up biotechs, with new biotech schools being planned as well. "Sector specific biotech parks will be set up at Mysore, Mangalore, Dharwad and Bidar in north Karnataka," said Karnataka Chief Minister B.S. Yeddyurappa. "Similarly, a bio-cluster will be set up in the Bangalore Biotech Park on a public-private partnership mode."